ZIM Laboratories reports mixed Q2 2025 results with consolidated loss

ZIM Laboratories Limited reported its unaudited consolidated financial results for the quarter ended September 30, 2025, with total income at INR 9,075.43 lakhs and total expenses at INR 9,109.81 lakhs, leading to a loss before tax of INR (34.38) lakhs. For the half-year ended September 30, 2025, consolidated total income reached INR 16,398.67 lakhs, with a loss before tax of INR (277.58) lakhs. Diluted earnings per share (EPS) for the quarter stood at INR (0.09).

On a standalone basis, the company reported a total income of INR 9,043.82 lakhs for the quarter and INR 16,334.15 lakhs for the half-year ended September 30, 2025. Standalone profit before tax for the quarter was INR 22.81 lakhs, while the half-year saw a loss before tax of INR (205.48) lakhs. Standalone diluted EPS for the quarter was INR 0.03.

The Board of Directors approved these results on November 12, 2025. The consolidated and standalone financial results for the comparable periods in 2024 and year ended March 31, 2025, were reviewed/audited by another auditor.